[Neusoft Group: Special fund plans to purchase 8.34% equity of Neusoft Medical for 1.083 billion yuan] On September 14, Neusoft Group (600718.SH) announced that the company's special fund as a limited partner plans to purchase 8.3412% of Neusoft Medical's equity held by Neusoft Holdings in cash, with a transaction consideration of 1.083 billion yuan. This transaction constitutes a related transaction and does not constitute a major asset restructuring, and it still needs to be submitted to the company's shareholders' meeting for review. Neusoft Medical will launch new products such as China's first photon counting CT and the world's first 1024-slice wide-body ultra-high-definition CT in 2025, and will gradually mass-produce machines in 2026, accelerating the launch of high-end products.